Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00052823" target="_blank" >RIV/00216224:14110/11:00052823 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/65269705:_____/11:#0001438

Výsledek na webu

<a href="http://dx.doi.org/10.1155/2011/981497" target="_blank" >http://dx.doi.org/10.1155/2011/981497</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1155/2011/981497" target="_blank" >10.1155/2011/981497</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children

Popis výsledku v původním jazyce

Thirty-two consecutive children aged 0?18 years with VTE treated with LMWH administered as a continuous infusion (CI) were identified at the Children?s University Hospital Brno. The treatment led to at least partial resolution of the thrombus within twoweeks in 85% of patients. There were no adverse events or increased bleeding reported in any patients. No recurrences were observed during a followup period of 6 months. Although continuous infusion should not replace subcutaneous (SC) administration ofLMWH, CI appeared to be safe and efficient and may provide an alternate method of administering LMWH in a subset of the paediatric population where SC administration may not be feasible. Further prospective studies are needed to support the promising findings of our pilot clinical observation.

Název v anglickém jazyce

Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children

Popis výsledku anglicky

Thirty-two consecutive children aged 0?18 years with VTE treated with LMWH administered as a continuous infusion (CI) were identified at the Children?s University Hospital Brno. The treatment led to at least partial resolution of the thrombus within twoweeks in 85% of patients. There were no adverse events or increased bleeding reported in any patients. No recurrences were observed during a followup period of 6 months. Although continuous infusion should not replace subcutaneous (SC) administration ofLMWH, CI appeared to be safe and efficient and may provide an alternate method of administering LMWH in a subset of the paediatric population where SC administration may not be feasible. Further prospective studies are needed to support the promising findings of our pilot clinical observation.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Thrombosis

ISSN

2090-1488

e-ISSN

—

Svazek periodika

Neuveden

Číslo periodika v rámci svazku

—

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

4

Strana od-do

"nestrankovano"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—